Profile photo Nadia Haj Mohammad

Nadia Haj Mohammad

Assistant Professor - medical

Strategic program(s):

Biography

Dr. N. Haj Mohammad (1976) has been working as a medical oncologist in the UMC Utrecht since 2014. She studied pharmacy in the same city, and completed her pharmacy training in 2001. One year earlier, she started Medical school at the University of Amsterdam. She combined her training as a medical-oncologist at the AMC with PhD research in the clinical outcomes of treatments for gastroesophageal and pancreatic carcinoma.

She is member of the national guidelines for hepatocellular carcinoma and bile duct carcinoma. She is a board member of the Dutch Upper GI Cancer group.

Her research focuses on clinical outcomes of gastroesophageal and primary liver cancers. She is national PI of the phase 2 LyRICX study in metastatic gastroesophageal cancer and is local PI of multiple investigator and sponsor investigated studies within tumors of the upper digestive tract and primary liver tumors.

Strategic program(s):

Contact

Research groups

Primary Liver Tumors research group

Research aim

To improve surveillance, diagnostics, treatment, and outcome for patients with primary liver tumors (hepatocellular carcinoma and cholangiocarcinoma) by interdisciplinary and (inter-)national collaborative research

Go to group

Recent publications

A cost-effectiveness analysis of the effect of hospital variation in the probability of providing treatment with curative intent in potentially curable esophageal and gastric cancer patients Saskia P M Truijen, Pauline A J Vissers, Grard A P Nieuwenhuijzen, Maurice J C van der Sangen, Peter D Siersema, Marije Slingerland, Nadia H Mohammad, Laurens V Beerepoot, Mark I van Berge Henegouwen, Pieter C van der Sluis, Camiel Rosman, Ewout A Kouwenhoven, Hüseyin Aktaş, Hanneke W M van Laarhoven, Carin A Uyl-de Groot, Rob H A Verhoeven
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2025, vol. 38
STRONG II trial Suus Y van Loosbroek, Maaike T W Milder, Dirk de Ruysscher, Rianne D W Vaes, Wilhelm den Toom, François Willemssen, Ferry Eskens, Marjolein Y V Homs, Bas Groot Koerkamp, Lydi M J W van Driel, Yvette Seppenwoolde, Erik van Werkhoven, Martijn Intven, Nadia Haj Mohammad, Joep de Bruijne, Eva Versteijne, Anna M Bruynzeel, Freek Brandts, Joris I Erdmann, Harm Westdorp, Pètra M Braam, Eric T T L Tjwa, Christelle Bouchart, Anne Demols, Akos Gulyban, Jeroen Buijsen, Judith de Vos-Geelen, Maxime Dewulf, Ines Joye, Timon Vandamme, Luisa Vonghia, Derk Jan de Groot, Margriet Dieters, Fred J F Ubbels, Frederik J H Hoogwater, Ben Heijmen, Alejandra Méndez Romero
BMJ Open, 2025, vol. 15
Incomplete neoadjuvant chemo(radio)therapy negatively impacts pathological response and overall survival in locally advanced esophageal cancer Denice Kamp, Samuel Noya, Stella Mook, Jelle P Ruurda, Richard van Hillegersberg, Jingpu Wang, Paul Jeene, Lodewijk A A Brosens, Anne M May, Rob H A Verhoeven, Hanneke W M van Laarhoven, Nadia Haj Mohammad
European Journal of Cancer, 2025, vol. 224
Quality of Life Among Patients With Locally Advanced Pancreatic Cancer Leonard W F Seelen, Simone Augustinus, Thomas F Stoop, Stefan A W Bouwense, Olivier R Busch, Geert A Cirkel, Casper H J van Eijck, Judith de Vos-Geelen, Bas Groot Koerkamp, Nadia Haj Mohammad, Ignace H J T de Hingh, Evelien van Alphen, Marjolein Y V Homs, Mike S L Liem, Maartje Los, Vincent E de Meijer, Leonie J M Mekenkamp, Mirjam A G Sprangers, Martijn W J Stommel, Johanna W Wilmink, Marc G Besselink, Hjalmar C van Santvoort, Hanneke W M van Laarhoven, I Quintus Molenaar,
Journal of the national comprehensive cancer network, 2025, vol. 23, p.97-104
Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer Denice Kamp, Anne M. May, Antoine Adenis, Andreia Capela, Sarah Derks, Francesca De Felice, Nina Fokter Dovnik, Cinta Hierro, Aysegul Ilhan-Mutlu, Florian Lordick, Radka Lordick Obermannova, Angelica Petrillo, Alberto Puccini, Ana Raimundo, Giandomenico Roviello, Alexander Siebenhüner, Marije Slingerland, Elizabeth C. Smyth, Hanneke W.M. van Laarhoven, Nadia Haj Mohammad
European Journal of Cancer, 2025, vol. 218
Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma Hanneke van Laarhoven, Rob Verhoeven, Mark van Berge Henegouwen, Nadia Haj Mohammad, Richard van Hillegersberg, Marije Slingerland, Christina T. Muijs, Bas Wijnhoven, Bianca Mostert, Laurens Beerepoot, Grard Nieuwenhuijzen, Sarah Derks, Peter S.N. van Rossum
EClinicalMedicine, 2025, vol. 80